impact factor
logo
 

Letters to the Editor

 

A new focus on thyrosine kinases inhibitors in eosinophilic granulomatosis with polyangiitis


1, 2, 3, 4, 5, 6, 7

 

  1. Rheumatology, Allergology and Clinical Immunology, Department of “Medicina dei Sistemi”, University of Rome Tor Vergata, Rome, Italy. triggianese@med.uniroma2.it
  2. Rheumatology, Allergology and Clinical Immunology, Department of “Medicina dei Sistemi”, University of Rome Tor Vergata, Rome, Italy.
  3. Rheumatology, Allergology and Clinical Immunology, Department of “Medicina dei Sistemi”, University of Rome Tor Vergata, Rome, Italy.
  4. Haematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.
  5. Rheumatology, Allergology and Clinical Immunology, Department of “Medicina dei Sistemi”, University of Rome Tor Vergata, Rome, Italy.
  6. Rheumatology, Allergology and Clinical Immunology, Department of “Medicina dei Sistemi”, University of Rome Tor Vergata, Rome, Italy.
  7. Rheumatology, Allergology and Clinical Immunology, Department of “Medicina dei Sistemi”, University of Rome Tor Vergata, Rome, Italy.

CER13553
2021 Vol.39, N°2 ,Suppl.129
PI 0180, PF 0181
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 33338003 [PubMed]

Received: 11/05/2020
Accepted : 08/06/2020
In Press: 02/12/2020
Published: 19/05/2021

Rheumatology Article